Android Apple

Shareholders Will Probably Be Cautious Of Increasing INmune Bio, Inc.'s (NASDAQ:INMB) CEO Compensation At The Moment

By Yahoo! Finance   |   5 months ago
Shareholders Will Probably Be Cautious Of Increasing INmune Bio, Inc.'s (NASDAQ:INMB) CEO Compensation At The Moment

INmune Bio's EPS declined by 4.8% over three years, resulting in a 59% loss for shareholders. Shareholders may express discontent at the AGM on July 19, especially regarding CEO compensation.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.